Anti-Interleukin-1 Therapy Does Not Affect the Response to SARS-CoV-2 Vaccination and Infection in Patients with Systemic Autoinflammatory Diseases

Anti-Interleukin-1 Therapy Does Not Affect the Response to SARS-CoV-2 Vaccination and Infection in Patients with Systemic Autoinflammatory Diseases

Patients with systemic autoinflammatory diseases (sAIDs) are a section of the population at high risk of severe COVID-19 outcomes, but evidence on the efficacy of SARS-CoV-2 vaccination in this group of patients is scarce. To investigate the efficacy of SARS-CoV-2 vaccination in patients with sAIDs...

Full description

Bibliographic Details
Main Authors: Leonie Geck, Koray Tascilar, David Simon, Arnd Kleyer, Georg Schett, Jürgen Rech
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Clinical Medicine
Subjects:
autoinflammatory diseases
SARS-CoV-2
vaccination
familial Mediterranean fever
adult-onset Still’s disease
cryopyrin-associated periodic syndrome
Online Access:https://www.mdpi.com/2077-0383/12/24/7587

Internet

https://www.mdpi.com/2077-0383/12/24/7587

Similar Items